Citation Impact
Citing Papers
The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP
2008 Standout
Tumor Genetic Analyses of Patients with Metastatic Renal Cell Carcinoma and Extended Benefit from mTOR Inhibitor Therapy
2014
Patterns of Gene Expression and Copy-Number Alterations in von-Hippel Lindau Disease-Associated and Sporadic Clear Cell Carcinoma of the Kidney
2009 StandoutNobel
Beyond Rapalog Therapy: Preclinical Pharmacology and Antitumor Activity of WYE-125132, an ATP-Competitive and Specific Inhibitor of mTORC1 and mTORC2
2010
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations
2013 Standout
Comprehensive Assessment of HIV Target Cells in the Distal Human Gut Suggests Increasing HIV Susceptibility Toward the Anus
2013
The von Hippel-Lindau gene
2008
Plasticenta: First evidence of microplastics in human placenta
2020 Standout
Biomarker Development for the Clinical Activity of the mTOR Inhibitor Everolimus (RAD001): Processes, Limitations, and Further Proposals
2010
EGFR Antagonists in Cancer Treatment
2008 Standout
Targeting hypoxia in cancer therapy
2011 Standout
mTOR Signaling in Growth Control and Disease
2012 Standout
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
2006 Standout
Inventory of prostate cancer predictive tools
2008
Novel mutant-selective EGFR kinase inhibitors against EGFR T790M
2009 StandoutNature
Next-generation mTOR inhibitors in clinical oncology: how pathway complexity informs therapeutic strategy
2011
Epithelial-Mesenchymal Transitions in Development and Disease
2009 Standout
Lipid nanoparticles for mRNA delivery
2021 Standout
The biology and management of non-small cell lung cancer
2018 StandoutNature
Phase II study of everolimus in patients with locally advanced or metastatic transitional cell carcinoma of the urothelial tract: clinical activity, molecular response, and biomarkers
2012
Epidermal growth factor receptor mutations in lung cancer
2007 Standout
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
2017 Standout
Periluminal Distribution of HIV-Binding Target Cells and Gp340 in the Oral, Cervical and Sigmoid/Rectal Mucosae: A Mapping Study
2015 StandoutNobel
Cancer drug resistance: an evolving paradigm
2013 Standout
Functionalized graphene sheets for polymer nanocomposites
2008 Standout
Osimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung Cancer
2016 Standout
Dasatinib in Imatinib-Resistant Philadelphia Chromosome–Positive Leukemias
2006 Standout
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
2014 StandoutNature
ICUD-EAU International Consultation on Bladder Cancer 2012: Radical Cystectomy and Bladder Preservation for Muscle-Invasive Urothelial Carcinoma of the Bladder
2012
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
2015 Standout
Effect of surface chemistry on nanoparticle interaction with gastrointestinal mucus and distribution in the gastrointestinal tract following oral and rectal administration in the mouse
2014
Combinations of Bevacizumab With Cancer Immunotherapy
2018
Bladder cancer
2016 Standout
Increased activated Akt expression in renal cell carcinomas and prognosis
2008
Evading tumor evasion: Current concepts and perspectives of anti-angiogenic cancer therapy
2010
Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug Delivery
2012 Standout
EGFR Mutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib
2005 Standout
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
2014 Standout
VHL, the story of a tumour suppressor gene
2014
Microbicides for HIV prevention: reality or hope?
2009
Human gelatin tissue-adhesive hydrogels prepared by enzyme-mediated biosynthesis of DOPA and Fe3+ion crosslinking
2013
Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study
2011 Standout
The PI3K Pathway in Human Disease
2017 Standout
Targeting PI3K signalling in cancer: opportunities, challenges and limitations
2009 Standout
Cancer as an evolutionary and ecological process
2006 Standout
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
HIV-1 Neutralization Profile and Plant-Based Recombinant Expression of Actinohivin, an Env Glycan-Specific Lectin Devoid of T-Cell Mitogenic Activity
2010 StandoutNobel
AZD9291 in EGFR Inhibitor–Resistant Non–Small-Cell Lung Cancer
2015 Standout
Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
2023 StandoutNobel
The Unexpected Importance of the Primary Structure of the Hydrophobic Part of One-Component Ionizable Amphiphilic Janus Dendrimers in Targeted mRNA Delivery Activity
2022 StandoutNobel
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
2008 Standout
Orthogonal Design of Experiments for Engineering of Lipid Nanoparticles for mRNA Delivery to the Placenta
2023 StandoutNobel
How To Build and Interpret a Nomogram for Cancer Prognosis
2008 Standout
The Intersection between Tumor Angiogenesis and Immune Suppression
2019
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials
2015 Standout
Targeting the mTOR Signaling Network for Cancer Therapy
2009
The global threat from plastic pollution
2021 StandoutScience
In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism
2023 StandoutNobel
Temsirolimus, an Inhibitor of Mammalian Target of Rapamycin
2008
Sampling, isolating and identifying microplastics ingested by fish and invertebrates
2016
Dynamic Mechanical and Thermal Properties of Phenylethynyl‐Terminated Polyimide Composites Reinforced With Expanded Graphite Nanoplatelets
2005
Prognostic nomogram and index for overall survival in previously untreated patients with chronic lymphocytic leukemia
2007
Molecular correlates of gefitinib responsiveness in human bladder cancer cells
2007
pVHL suppresses kinase activity of Akt in a proline-hydroxylation–dependent manner
2016 StandoutScienceNobel
Are We Speaking the Same Language? Recommendations for a Definition and Categorization Framework for Plastic Debris
2019 Standout
Defining High Risk Prostate Cancer With Risk Groups and Nomograms: Implications for Designing Clinical Trials
2006
mTOR: a pharmacologic target for autophagy regulation
2015 Standout
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
Throughput-scalable manufacturing of SARS-CoV-2 mRNA lipid nanoparticle vaccines
2023 StandoutNobel
Tissue-Based Research in Kidney Cancer: Current Challenges and Future Directions
2008
Epidermal Growth Factor Receptor Mutations and Gene Amplification in Non–Small-Cell Lung Cancer: Molecular Analysis of the IDEAL/INTACT Gefitinib Trials
2005
Detection of Various Microplastics in Human Stool
2019 Standout
Works of Daniel Cho being referenced
Treatment selection for patients with metastatic renal cell carcinoma
2009
Potential Histologic and Molecular Predictors of Response to Temsirolimus in Patients with Advanced Renal Cell Carcinoma
2007
Preliminary results for avelumab plus axitinib as first-line therapy in patients with advanced clear-cell renal-cell carcinoma (JAVELIN Renal 100): an open-label, dose-finding and dose-expansion, phase 1b trial
2018
Bioinspired Bioadhesive Polymers: Dopa‐Modified Poly(acrylic acid) Derivatives
2012
Unusual Cases in Multiple Myeloma and a Dramatic Response in Metastatic Lung Cancer
2004
798 Safety, tolerability, and immunogenicity of mRNA-4157 in combination with pembrolizumab in subjects with unresectable solid tumors (KEYNOTE-603): an update
2020
Unique insights into the intestinal absorption, transit, and subsequent biodistribution of polymer-derived microspheres
2013
Pretreatment Nomogram That Predicts 5-Year Probability of Metastasis Following Three-Dimensional Conformal Radiation Therapy for Localized Prostate Cancer
2003
PROSPECTIVELY PACKAGED LYMPH NODE DISSECTIONS WITH RADICAL CYSTECTOMY: EVALUATION OF NODE COUNT VARIABILITY AND NODE MAPPING
2004
Characterization of Baseline Intestinal Mucosal Indices of Injury and Inflammation in Men for Use in Rectal Microbicide Trials (HIV Prevention Trials Network-056)
2007
Simultaneous monitoring of the imidization and cure reactions of LaRC PETI-5 sized on a braided glass fabric substrate by dynamic mechanical analysis
2001
Response of Renal Cell Carcinoma Pancreatic Metastasis to Sunitinib Treatment: A Retrospective Analysis
2009
The Role of Mammalian Target of Rapamycin Inhibitors in the Treatment of Advanced Renal Cancer
2007